Petros Family Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$326K Buy
1,295
+178
+16% +$38.3K 0.2% 98
2026
Q1
$243K Sell
1,117
-914
-45% -$203K 0.17% 114
2025
Q4
$464K Sell
2,031
-1,155
-36% -$263K 0.31% 83
2025
Q3
$738K Sell
3,186
-91
-3% -$18.5K 0.62% 46
2025
Q2
$608K Buy
3,277
+44
+1% +$8.18K 0.56% 50
2025
Q1
$677K Buy
3,233
+8
+0.2% +$1.55K 0.75% 40
2024
Q4
$573K Buy
+3,225
New +$593K 0.62% 45

Other funds holding ABBV

Petros Family Wealth's ABBV Position: Q2 2026 in Review

Petros Family Wealth increased its AbbVie (ABBV) stake by 16% in Q2 2026, buying an estimated $38.3K and bringing the position to 1,295 shares worth $326K. The position accounts for 0.2% of the portfolio, ranked #98.

Petros Family Wealth first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $738K in Q3 2025. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Petros Family Wealth held 1,295 shares of AbbVie worth $326K as of Q2 2026.
  • Petros Family Wealth bought 178 AbbVie shares in Q2 2026, an estimated $38.3K.
  • AbbVie made up 0.2% of Petros Family Wealth's portfolio in Q2 2026, its #98 holding.
  • Petros Family Wealth first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Petros Family Wealth's AbbVie position peaked at $738K in Q3 2025.
  • 1,601 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Petros Family Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.